ストックスクリーナーアプリを入手
92.58
0.47%
-0.44
アフターアワーズ：
92.58
Guardant Health Inc (GH) 最新ニュース
BIAF vs. GH: Which Cancer Detection Stock Is the Better Buy Now? - Finviz
TEM's Diagnostics Arm Expanding Rapidly: What's Driving the Growth? - Yahoo Finance
Legato Capital Management LLC Has $677,000 Position in Guardant Health, Inc. $GH - MarketBeat
Amova Asset Management Americas Inc. Has $47.12 Million Position in Guardant Health, Inc. $GH - MarketBeat
ARK Investment Management LLC Sells 2,028,263 Shares of Guardant Health, Inc. $GH - MarketBeat
Guardant Health Targets Early Detection Growth With New Partner And Acquisition - simplywall.st
Shield mobile tour brings FDA-approved screening to 100 communities, Guardant Health announces - Traders Union
Guardant Health Launches Coast-to-Coast Screening Tour, Bringing Shield Colon Cancer Blood Test to Over 100 Communities Across America - Guardant Health
Blood test bus tour brings colon cancer screening to 100+ towns - Stock Titan
Segall Bryant & Hamill LLC Increases Stock Position in Guardant Health, Inc. $GH - MarketBeat
Actor and Cancer Advocate Patrick Dempsey Partners with Guardant Health to Raise Awareness about Colorectal Cancer Screening and Shield Blood Test, Sharing His Experience Getting Screened - Guardant Health
GH Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Intech Investment Management LLC Has $3.19 Million Stock Holdings in Guardant Health, Inc. $GH - MarketBeat
TD Asset Management Boosts Guardant Health Holdings - National Today
Guardant Health (GH) director acquires 154 shares via RSU vesting - Stock Titan
Guardant Health, Inc. (GH) Stock Analysis: A 41% Upside Potential With Strong Buy Ratings - DirectorsTalk Interviews
TD Asset Management Inc Boosts Holdings in Guardant Health, Inc. $GH - MarketBeat
Guardant Health, Inc. (GH) Strengthens Health Technology Portfolio with MetaSight Diagnostics Acquisition - Finviz
TD Cowen Health Care Conference - marketscreener.com
Guardant Health (GH) Is Down 8.9% After Issuing 2026 Guidance And New Equity Shelf Registration – Has The Bull Case Changed? - Yahoo Finance
11 Best Cancer Stocks to Invest In Now - Insider Monkey
Clover Health, Alignment Healthcare, Solventum, ANI Pharmaceuticals, and Guardant Health Shares Plummet, What You Need To Know - The Globe and Mail
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
Erste Asset Management GmbH Buys 66,617 Shares of Guardant Health, Inc. $GH - MarketBeat
Colon cancer screening expands with simple blood test as cases rise among under-50s - WLUK
Guardant Health (GH) Gained from Better-Than-Expected Results - Insider Monkey
Guardant Health Stock Hits Day Low at $94.62 Amid Price Pressure - Markets Mojo
Guardant Health, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:GH) 2026-02-25 - Seeking Alpha
Guardant Health Stock Hits Day Low of $93.79 Amid Price Pressure - Markets Mojo
Single‑Reference Disclosures and the Motivation‑to‑Combine Requirement - The National Law Review
Liquidity Mapping Around (GH) Price Events - Stock Traders Daily
Piper Sandler Raises Guardant Health (GH) Price Target to $130 | - GuruFocus
Vanguard Group Inc. Reduces Position in Guardant Health, Inc. $GH - MarketBeat
Guardant Health acquires Israeli healthtech MetaSight for up to $150M - MSN
Guardant Health pushes for AI-driven oncology breakthroughs at Cancer 2035 - Traders Union
Guardant Health slides as investors digest Q4 results and a risk-off tape - Quiver Quantitative
Guardant Health, Inc. (GH) Stock Analysis: A 26.53% Upside Potential in the Precision Oncology Market - DirectorsTalk Interviews
Guardant Health acquires MetaSight amid positive 2026 financial outlook - Yahoo Finance
Guardant Health, PacBio, Align Technology, QuidelOrtho, and Omnicell Shares Are Falling, What You Need To Know - Finviz
Guardant buys MetaSight for $59M upfront to acquire blood test tech - MedTech Dive
Guardant Health Expands Cancer Testing Platform With MetaSight Deal And Shield Growth - Yahoo Finance
Skandinaviska Enskilda Banken AB publ Trims Holdings in Guardant Health, Inc. $GH - MarketBeat
Granite Investment Partners LLC Lowers Stake in Guardant Health, Inc. $GH - MarketBeat
Guardant Health Leads the Way in Blood-Based Single Cancer Screening - Morningstar
Can Guardant Health Inc. keep up with sector leadersMarket Risk Summary & Accurate Intraday Trade Tips - mfd.ru
State of New Jersey Common Pension Fund D Has $2.55 Million Holdings in Guardant Health, Inc. $GH - MarketBeat
Canaccord Genuity Group Forecasts Strong Price Appreciation for Guardant Health (NASDAQ:GH) Stock - Defense World
Guardant Health (NASDAQ:GH) Stock Price Expected to Rise, Leerink Partners Analyst Says - Defense World
Guardant Health Earnings Call Highlights Growth And Burn - TipRanks
Analysts Have Conflicting Sentiments on These Healthcare Companies: Biogen (BIIB), Guardant Health (GH) and PTC Therapeutics (PTCT) - The Globe and Mail
Hillsdale Investment Management Inc. Acquires 19,800 Shares of Guardant Health, Inc. $GH - MarketBeat
Jupiter Asset Management Ltd. Purchases New Stake in Guardant Health, Inc. $GH - MarketBeat
Guardant Health (GH) Receives Maintained In-Line Rating with Rai - GuruFocus
Guardant Health, Inc. $GH Shares Acquired by Assetmark Inc. - MarketBeat
Citigroup Raises Price Target for Guardant Health (GH) to $150 | - GuruFocus
Aberdeen Group plc Decreases Stake in Guardant Health, Inc. $GH - MarketBeat
Guardant Health (GH) Sees Analyst Rating Update by JP Morgan | G - GuruFocus
Leerink Partners Maintains Outperform Rating on Guardant Health (GH) | GH Stock News - GuruFocus
2.14%
0.35%
大文字化:
|
ボリューム (24 時間):